(Q43281500)

18 November 2017

title

Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy (English)

1 reference

adaptive radiation therapy

18 November 2017

main subject

0 references

1 reference

1 reference

head and neck carcinoma

1 reference

7

Michael Baumann

1 reference

18 November 2017

Maria Hentschel

1

1 reference

18 November 2017

Steffen Appold

2

1 reference

18 November 2017

Andreas Schreiber

3

1 reference

18 November 2017

Andrij Abramyuk

4

1 reference

18 November 2017

Nasreddin Abolmaali

5

1 reference

18 November 2017

Joerg Kotzerke

6

1 reference

18 November 2017

Klaus Zöphel

8

1 reference

18 November 2017

language of work or name

1 reference

1 September 2009

1 reference

International Journal of Radiation Biology

18 November 2017

published in

1 reference

18 November 2017

volume

85

1 reference

18 November 2017

issue

9

1 reference

18 November 2017

page(s)

796-804

1 reference

Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

A gradient-based method for segmenting FDG-PET images: methodology and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Partial-volume effect in PET tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

Current status of FDG-PET for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09553000903039180

10.1080/09553000903039180

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference